Get the Stockscreener App
2.57
21.90%
0.47
Quantum Biopharma Ltd stock is traded at $2.57, with a volume of 3.10M.
It is up +21.90% in the last 24 hours and down -29.86% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$2.10
Open:
$2.23
24h Volume:
3.10M
Relative Volume:
24.85
Market Cap:
$9.91M
Revenue:
-
Net Income/Loss:
$-28.71M
P/E Ratio:
-0.2505
EPS:
-10.2587
Net Cash Flow:
$-8.77M
1W Performance:
-28.69%
1M Performance:
-29.86%
6M Performance:
-70.28%
1Y Performance:
+12.78%
1-Day Range:
$2.11
$3.20
1-Week Range:
$2.07
$3.75
52-Week Range:
$2.07
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
2.58 | 8.07M | 0 | -28.71M | -8.77M | -10.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.88 | 125.08B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.07 | 81.90B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
711.36 | 45.06B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.13 | 42.50B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
287.24 | 33.16B | 5.36B | 287.73M | 924.18M | 2.5229 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Quantum BioPharma Provides Corporate Update - The Manila Times
Quantum BioPharma Ltd. Revises Terms of Debenture Units Following Market Price Decrease - Quiver Quantitative
Quantum BioPharma Provides Corporate Update - GlobeNewswire Inc.
Quantum BioPharma Plans Convertible Debenture Financing and Debt-for-Equity Swap Ahead of 2025 Results - TipRanks
Trade Recap: Will Quantum BioPharma Ltd outperform during market rallies2026 Pullback Review & Consistent Income Trade Recommendations - baoquankhu1.vn
Quantum BioPharma Ltd. announced that it expects to receive CAD 4 million in funding - marketscreener.com
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - Shelby Star
Aug PostEarnings: Whats the fair value of Quantum BioPharma Ltd stockVolume Spike & Weekly Setup with ROI Potential - baoquankhu1.vn
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
A | What’s the fair value of Quantum BioPharma Ltd. stockM&A Rumor & Consistent Profit Alerts - mfd.ru
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - PR Newswire
Entry Recap: Should I hold or sell Quantum BioPharma Ltd nowTrade Volume Report & Technical Pattern Alert System - baoquankhu1.vn
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors - marketscreener.com
Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors - GlobeNewswire
QNTM PE Ratio & Valuation, Is QNTM Overvalued - Intellectia AI
FinancialContentCONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM - FinancialContent
User - The Chronicle-Journal
Quantum Biopharma Ltd. Class Action Notice for Investors - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors - GlobeNewswire
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming DeadlinesQNTM - Prime Publishers, Inc.
Quantum Biopharma Shareholders File Class Action Lawsuit - Intellectia AI
Targets Report: Will Quantum BioPharma Ltd stock benefit from M A2025 Bull vs Bear & Free Community Consensus Stock Picks - baoquankhu1.vn
Will Quantum BioPharma Ltd stock benefit from M AMarket Trend Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quantum Biopharma Ltd. Class Action Alert for Investors - intellectia.ai
Quantum Biopharma Reports Q3 2025 Financial Results - MSN
QNTM Stockholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
Risk Recap: Will QNTM stock go up in YEARJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
QNTM Shareholders Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QNTM Investors Have Opportunity to Lead Quantum Biopharma Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Quantum Biopharma Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud - intellectia.ai
Quantum BioPharma Heads For Best Week Ever — But Most Retail Traders Lament Missing Out On The Surge - MSN
Why Quantum BioPharma Ltd. (0K91) stock signals breakout potentialWeekly Stock Analysis & Weekly Watchlist for Hot Stocks - bollywoodhelpline.com
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - accessnewswire.com
Quantum Biopharma Ltd Stock (QNTM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):